Related Experiment Video
Updated: Aug 2, 2026

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
Ileal Gene Expression Data from Crohn's Disease Small Bowel Resections Indicate Distinct Clinical Subgroups
Alka A Potdar1, Dalin Li1, Talin Haritunians1
1F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Researchers identified three subgroups within severe Crohn's disease (CD). One subgroup (CD3) shows higher recurrence and surgery rates, indicating a need for targeted therapies based on genetic and molecular signatures.
Area of Science:
- Gastroenterology
- Molecular Biology
- Genetics
Background:
- Crohn's disease (CD) heterogeneity complicates treatment development.
- Identifying distinct molecular profiles in severe, refractory CD is crucial for precision medicine.
Purpose of the Study:
- To define a unique molecular signature for severe, refractory CD.
- To enable precision therapy and earlier intervention for complicated CD cases.
Main Methods:
- Analysis of clinical data, genetics, and transcriptomics from uninvolved ileal tissue of CD patients.
- Determination of transcriptional risk scores, cellular signatures, and mechanistic pathways to define patient subsets.
Main Results:
- Three refractory CD subgroups (CD1, CD2, CD3) were identified.
- CD3 subgroup showed increased disease recurrence, higher rates of second surgery, and perianal CD presence.
- CD3 subgroup exhibited shorter recurrence-free survival, associated with eukaryotic initiation factor 2 (eIF2) and cyclic adenosine monophosphate (cAMP) signaling pathways, and enriched eosinophil and natural killer T (NKT) cell signatures.
Conclusions:
- A distinct subset of severe, refractory CD patients requiring aggressive treatment post-resection was characterized.
- This subset may benefit from targeted therapies informed by their specific genotype and tissue gene expression profile.
Related Concept Videos
Renewal of Intestinal Stem Cells
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease IV: Clinical Manifestations

